Skip to content Skip to Search
Skip navigation

Saudi pharma firm to buy manufacturing site in Algeria

By Andy Sambidge
Jamjoon Pharmaceuticals raised $336 million in an initial public offering earlier this year Unsplash/Volodymyr Hryshchenko
Jamjoon Pharmaceuticals raised $336 million in an initial public offering earlier this year
  • Jamjoon increases investment in joint venture
  • Plant in Algiers produces tablets, capsules and powders
  • Saudi pharma industry worth $11.7bn

Jamjoom Pharmaceuticals Factory Company has increased capital in its joint venture in Algeria to help finance the acquisition of a manufacturing facility.

In a filing to the Saudi Stock Exchange, the company, which raised $336 million in an initial public offering in May, announced the additional funding in Jamjoom Algeria Lil Dawa, in which it owns 49 percent. 

The tie-up with Dawa Investment will create and issue 2.2 million new shares, with the capital increasing to $17.3 million.

The latest cash injection will partially fund the purchase of a site in Algiers, with an initial payment of $14 million. 

It will also finance the day-to-day factory operations, Jamjoon said in the filing, adding that it has invested $8 million with the remainder financed by a Shariah-compliant banking facility agreement between the joint venture and a bank in Algeria.

The factory produces a range of tablets, capsules and powders and is expected to begin operations immediately with the company seeing a financial impact from Q3 onwards.

Earlier this month, Jamjoom reported net profit of $22.5 million for the first quarter of 2023, up 94 percent compared to the previous year. 

The company generated revenue of $80.5 million in Q1, an increase of 24 percent on the back of strong demand for its products.

In May, Jamjoom’s IPO secured two cornerstone investors – Saudi Economic and Development Holding Co and Al Faisaliah Group – who subscribed for almost a quarter of the offering. 

The business develops, manufactures and markets a range of branded pharmaceutical products, with its main facility in Jeddah delivering 113 million units per year.

Analysts at BMI, formerly Fitch Solutions, expect pharmaceutical investment in Saudi Arabia to grow strongly, describing the market as an “attractive business landscape”.

The Saudi pharmaceutical industry was valued at $11.7 billion last year, according to BMI, and is estimated to grow annually at over 5 percent to $15.1 billion in 2027 and $19.8 billion in 2032. 

Latest articles

An extension of Diriyah's Bujairi Terrace, a popular nightspot, will open in November

Diriyah giga-project to open first hotel in November

Diriyah, one of Saudi Arabia’s leading giga-projects, will finally open its first hotel in November along with other attractions and sites, its CEO said this week.  “This November we’ll open another few kilometres of parks, we’ll open our first Bab Samhan hotel, we’ll open our first museum which is the Diriyah Art Futures Museum, we’ll […]

King Abdulaziz International Airport: the number of international flights increased but there were less than 27.4 million international visitors to the kingdom last year

Passenger numbers rise 26% in Saudi Arabia

Saudi Arabia said this week that its total number of air passengers rose 26 percent to 112 million in 2023. This includes a 46 percent rise in the total number of international travellers to 61 million.  The number means the kingdom’s airports are approaching full capacity, which is 116 million passengers a year, including 45 […]

Oil workers in Venezuela, a founder member of Opec. The IEA predicts slower demand growth

IEA and Opec move further apart on global oil demand

The division between the International Energy Agency and oil producers’ group Opec has deepened as the Paris-based energy watchdog once again curtailed its oil demand outlook for 2024, amid softer macro sentiment. In its monthly report, the IEA forecast on Wednesday that world fuel demand will grow by 1.1 million barrels per day (bpd) this […]

Tourists visit the tombs of the Nabatean civilisation in AlUla. Saudi Arabia's goal is for tourism to make up 10 percent of GDP by 2030

Affluent tourists around the globe on Saudi Arabia’s radar

Saudi Arabia will invest more than $800 billion in its main giga-projects by the next decade as part of a tourism expansion strategy focused on affluent tourists in China, India and Europe.  The kingdom’s tourism minister Ahmed Al-Khateeb, speaking at the Qatar Investment Forum, said: “We’re building and investing in major destinations like Neom, Red […]